Related Experiment Videos
Decrease of inorganic blood sulfate following treatment with selected antirheumatic drugs: potential consequence for
B J de Vries1, P M van der Kraan, W B van den Berg
1Department of Rheumatology, Academic Hospital Sint Radboud, Nijmegen, The Netherlands.
Agents and Actions
|March 1, 1990
Summary
Certain antirheumatic drugs significantly lower blood sulfate levels in mice. This effect was observed with drugs like aspirin and phenylbutazone, but not with others such as ibuprofen.
Area of Science:
- Pharmacology
- Biochemistry
- Rheumatology
Background:
- Inorganic blood sulfate levels are influenced by various physiological and pharmacological factors.
- Articular cartilage integrity is a critical concern in rheumatic diseases.
- Understanding drug-induced changes in sulfate metabolism may offer insights into therapeutic mechanisms.
Purpose of the Study:
- To investigate the impact of common antirheumatic drugs on inorganic blood sulfate levels in a murine model.
- To identify which classes of antirheumatic drugs possess sulfate-lowering properties.
- To explore the potential implications of these findings for articular cartilage health.
Main Methods:
- Oral administration of various antirheumatic drugs to mice at specified dosages.
- Measurement of inorganic blood sulfate concentrations over a four-hour period post-administration.
- Comparison of sulfate levels in drug-treated groups against control groups.
Main Results:
- Sodium salicylate, aspirin, diflunisal, benorylate, phenylbutazone, oxyphenbutazone, chloroquine diphosphate, and tiaprofenic acid significantly reduced blood sulfate levels.
- Drugs including niflumic acid, piroxicam, indomethacin, diclofenac, ketoprofen, naproxen, and ibuprofen did not exhibit sulfate-lowering properties.
- The observed reduction in sulfate levels varied among the effective drugs.
Conclusions:
- A subset of antirheumatic drugs demonstrates a capacity to lower inorganic blood sulfate levels in mice.
- The study highlights differential effects of antirheumatic agents on sulfate metabolism.
- Further research is warranted to elucidate the relevance of sulfate-lowering effects for articular cartilage integrity and therapeutic outcomes.